Basilea Pharmaceutica AG

SWX:BSLN Stock Report

Market Cap: CHF 487.9m

Basilea Pharmaceutica Dividends and Buybacks

Dividend criteria checks 0/6

Basilea Pharmaceutica does not have a record of paying a dividend.

Key information

0%

Dividend yield

-0.7%

Buyback Yield

Total Shareholder Yield-0.7%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ratio0%

Recent dividend and buyback updates

No updates

Recent updates

Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Apr 18
Shareholders May Be More Conservative With Basilea Pharmaceutica AG's (VTX:BSLN) CEO Compensation For Now

Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Sep 20
Does Basilea Pharmaceutica (VTX:BSLN) Deserve A Spot On Your Watchlist?

Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Feb 17
Robust Earnings May Not Tell The Whole Story For Basilea Pharmaceutica (VTX:BSLN)

Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Jul 01
Revenue Downgrade: Here's What Analysts Forecast For Basilea Pharmaceutica AG (VTX:BSLN)

Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

Mar 24
Analysts Expect Breakeven For Basilea Pharmaceutica AG (VTX:BSLN) Before Long

If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Feb 18
If You Had Bought Basilea Pharmaceutica's (VTX:BSLN) Shares Three Years Ago You Would Be Down 19%

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if BSLN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BSLN's dividend payments have been increasing.


Dividend Yield vs Market

Basilea Pharmaceutica Dividend Yield vs Market
How does BSLN dividend yield compare to the market?
SegmentDividend Yield
Company (BSLN)0%
Market Bottom 25% (CH)2.0%
Market Top 25% (CH)4.3%
Industry Average (Biotechs)1.6%
Analyst forecast (BSLN) (up to 3 years)0%

Notable Dividend: Unable to evaluate BSLN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BSLN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: BSLN is not paying a notable dividend for the Swiss market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as BSLN has not reported any payouts.


Discover strong dividend paying companies